title: Rhazes viewpoints about causes, diagnosis, treatment and prognosis of gout.
abstract: Gout, a medical condition of acute inflammatory joint disorders, has been recognized from the antiquity. However, the name of Rhazes, a Persian historic physician who has described the etiology, signs, symptoms, epidemiology, treatment and prevention of this malady more than a thousand year ago, hasn't been taken into consideration appropriately. In this article, we studied and reported several chapters of Alhawi which is considered the most important Rhazes's medical textbook, focussing on his hypotheses because he has described this disease more manifestly. His original manuscripts are originally written in Arabic and they hadn't been translated to Persian until 1998. We intend to compare Rhazes opinions about gout with those of the literature in the area of rheumatology. According to our findings, Rhazes documented the symptoms of gout and categorized them scientifically. His insights about the treatment of gout, side effects of pharmacotherapy and management of the patients are so interesting and wonderful. Generally most of Rhazes viewpoints about gout are correct and compatible with recent findings. More investigation on Rhazes' viewpoints can guide us to propose more reliable hypothesis and schematize cost effective studies by delving into past medical records.
authors.affiliation: Professor of Psychiatry, Medical Ethics and History of Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran.
authors.forename: Seyed Mahmoud
authors.initials: SM
authors.lastname: Tabatabaei
authors.forename: Seyed Mohammad Ali
authors.initials: SM
authors.lastname: Tabatabaei
authors.forename: Mohammad Mahdi
authors.initials: MM
authors.lastname: Zamani
authors.forename: Nastaran
authors.initials: N
authors.lastname: Sabetkish
authors.forename: Farnaz
authors.initials: F
authors.lastname: Roshani
keywords: Gout; History of medicine; Iranian traditional medicine; Rhazes
references.citation: J Rheumatol. 2002 Feb;29(2):331-4
references.pmid: 11838852
references.citation: J Rheumatol. 2006 Oct;33(10):1921-2
references.pmid: 17014007
references.citation: Nature. 2006 Mar 9;440(7081):237-41
references.pmid: 16407889
references.citation: Rheumatology (Oxford). 2004 Aug;43(8):1054
references.pmid: 15258292
references.citation: Bull NYU Hosp Jt Dis. 2008;66(3):231-9
references.pmid: 18937638
references.citation: N Engl J Med. 2004 Mar 11;350(11):1093-103
references.pmid: 15014182
references.citation: Aust N Z J Med. 1987 Jun;17(3):301-4
references.pmid: 3314832
references.citation: Arthritis Rheum. 2005 Jan;52(1):283-9
references.pmid: 15641075
references.citation: Rheumatology (Oxford). 2008 May;47(5):732-3
references.pmid: 18356175
references.citation: Curr Opin Rheumatol. 2000 May;12(3):228-34
references.pmid: 10803754
references.citation: Arthritis Res Ther. 2006;8 Suppl 1:S3
references.pmid: 16820042
references.citation: Lancet. 2004 Apr 17;363(9417):1277-81
references.pmid: 15094272
references.citation: Dtsch Arztebl Int. 2009 Aug;106(34-35):549-55
references.pmid: 19795010
references.citation: J Clin Rheumatol. 2008 Oct;14(5 Suppl):S55-62
references.pmid: 18830092
references.citation: Clin Interv Aging. 2010 Feb 02;5:7-18
references.pmid: 20169038
references.citation: Ann Rheum Dis. 2005 Feb;64(2):267-72
references.pmid: 15647434
references.citation: Ann Rheum Dis. 2006 Oct;65(10):1301-11
references.pmid: 16707533
references.citation: Childs Nerv Syst. 2007 Nov;23(11):1225-6
references.pmid: 17541607
references.citation: Arch Iran Med. 2011 Jan;14(1):73-5
references.pmid: 21194269
references.citation: J Biol Chem. 1997 Apr 4;272(14):9496-502
references.pmid: 9083090
references.citation: Curr Opin Rheumatol. 2007 Mar;19(2):128-33
references.pmid: 17278927